Back to Rare Disease
NCT07051213
NCT07051213
Who may be able to join
Who might be able to join this trial:
- You have a moderate to profound intellectual disability or developmental delay
- You have a mild to moderate intellectual disability or developmental delay, AND more than one family member is affected, AND both parents are unaffected
- You have a mild to moderate intellectual disability or developmental delay, AND you have at least 3 well-documented minor physical differences (such as unusual facial features or body characteristics)
- You have one major physical abnormality present from birth, AND at least 3 well-documented minor physical differences
- You have two or more major physical abnormalities affecting different parts of the body (for example, the heart and the kidneys)
Who may not be able to join:
- There is reason to believe the condition was caused by something that happened before or during birth, such as an infection during pregnancy or exposure to harmful substances (like alcohol or certain medications) before birth
- You have already had advanced genetic testing, such as a large gene panel test or a whole-exome analysis (a broad genetic sequencing test), carried out previously
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Trial details
Status
Completed
Phase
Not Applicable
Sponsor
Universitaire Ziekenhuizen KU Leuven
Registry
clinicaltrials_gov
Start date
2 June 2021
Est. completion
5 July 2024
Where this trial is recruiting
🇧🇪 Belgium
Primary endpoints
Whole genome sequencing (WGS) performance compared to Whole exome sequencing (WES) performance
Can't join this trial?
Data last synced from ClinicalTrials.gov: 30 June 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.